StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Cytiva (Global Life Sciences Solutions) by Quarter

Cytiva (Global Life Sciences Solutions) — U.S. Federal Contracts (BARDA / HHS / NIH) ($M)

QuarterlyAnnual

Danaher Cytiva (Global Life Sciences Solutions): $0.94M in Q3 2026, up 59.3% from a year earlier.

Latest, Q3 2026
0.94
Period ended Sep 30, 2026
Change on a year earlier
+59.3%
0.59 in Q3 2025
History
39 quarters
Since Q1 2017
Sources
1
U.S. Treasury USAspending.gov API (Federal Contract Obligations)

Where the Q3 2026 figure comes from

Source: U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗

Reported in U.S. Treasury USAspending.gov API.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCytiva (Global Life Sciences Solutions) — U.S. Federal Contracts (BARDA / HHS / NIH) ($M)Year on yearSource
Q3 2026Sep 30, 20260.94+59.3%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q2 2026Jun 30, 20260.25-47.9%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q1 2026Mar 31, 20260.05-77.3%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q4 2025Dec 31, 20250.12-58.6%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q3 2025Sep 30, 20250.59-49.1%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q2 2025Jun 30, 20250.48-41.5%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q1 2025Mar 31, 20250.22-101.1%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q4 2024Dec 31, 20240.29-58.0%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q3 2024Sep 30, 20241.16-98.8%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q2 2024Jun 30, 20240.82+645.5%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q1 2024Mar 31, 2024-19.8-10,515.8%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q4 2023Dec 31, 20230.69+590.0%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q3 2023Sep 30, 202394.5+3,464.9%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q2 2023Jun 30, 20230.11-60.7%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q1 2023Mar 31, 20230.19-50.0%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗
Q4 2022Dec 31, 20220.10-44.4%U.S. Treasury USAspending.gov API (Federal Contract Obligations) ↗

Cite this data

StockData. (2026). Danaher Cytiva (Global Life Sciences Solutions) ($M), quarterly Q1 2017–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-usa-cytiva

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.